| NO | ផលិតផល | លេខ CAS | ការដាក់ពាក្យ | សូចនាករគុណភាពសំខាន់ៗ | ||||
| ភាពបរិសុទ្ធ | អ៊ីសូមឺរ | ភាពមិនបរិសុទ្ធជាក់លាក់ | * អតិបរមា 1 | សំណើម | ||||
| 1 | Fmoc-Cys(Acm)-OH | 86060-81-3 | ចំណង disulfide | ≥ 99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 2 | Fmoc-Cys(Mmt)-OH | ១៧៧៥៨២-២១-៧ | ចំណង disulfide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 3 | Fmoc-Cys (4-allylbutyrate)-OH | / | ចំណង disulfide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | Mpa(Trt)-OH | 27144-18-9 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 5 | Fmoc-Thr(tBu)-OL | 189337-28-8 | ថ្នាំ Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
| 6 | Fmoc-D-Arg(pbf)-OH | 187618-60-6 | ថ្នាំ Desmopressin | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
| 7 | Fmoc-Gly-Gly-OH | ៣៥៦៦៥-៣៨-៤ | ប៊ីវ៉ាលីរូឌីន | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 8 | Fmoc-Gly-Gly-Gly-OH | ១៧០៩៤១-៧៩-៤ | ថ្នាំ Terlipressin | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 9 | Fmoc-Gly-Gly-Gly-Gly-OH | / | ប៊ីវ៉ាលីរូឌីន | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 10 | Fmoc-Gly-Asp(tBu)-OH | / | ប៊ីវ៉ាលីរូឌីន | ≥ 99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
| 11 | Boc-Cys(Trt)-OH | 21947-98-8 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 12 | Boc-Arg (pbf)-OH | 200124-22-7 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 13 | បូក-អាឡា-អូ | 15761-38-3 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 14 | Boc-D-Phe-OH | 18942-49-9 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 15 | Boc-Gly-OH | 4530-20-5 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 16 | Boc-Lys(Boc)-OH.DCHA | 15098-69-8 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 17 | Boc-Ser(tBu)-OH | ៧៧៣៨-២២-៩ | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 18 | Boc-Thr(tBu)-OH | 13734-40-2 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 19 | Boc-D-Ala-OH | ៧៧៦៤-៩៥-៦ | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 20 | Boc-Met-OH | ២៤៨៨-១៥-៥ | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 21 | Boc-Tyr(tBu)-OH | 47375-34-8 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 22 | Boc-D-Arg (pdf)-OH | 187618-60-6 | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 23 | Boc-Asp(OtBu)-OH.DCHA | ១៩១៣/១២/៨ | ចុងបញ្ចប់នៃលំដាប់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 24 | Fmoc-HomoArg(pbf)-OH | 1159680-21-3 | Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
| 25 | Fmoc-Asp-OtBu | 129460-09-9 | ថ្នាំ Thymalfasin | ≥ 99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 26 | Fmoc-Tyr(Me)-OH | 77128-72-4 | កាបូតូស៊ីន | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 27 | Fmoc-Orn(Boc)-OH | 109425-55-0 | អាតូស៊ីបាន Omnipressin ដាបតូមីស៊ីន | ≥ 99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
| 28 | Fmoc-D-Tyr(Et)-OH | 162502-65-0 | អាតូស៊ីបាន | ≥ 99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 29 | Fmoc-Asp(OAll)-OH | 146982-24-3 | មេឡាណូតាន | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 30 | អា-ណល-អូ | 15891-49-3 | មេឡាណូតាន | ≥ 99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 31 | Fmoc-Nle-OH | 77284-32-3 | មេឡាណូតាន អាហ្វាម៉ាឡាណូទីត | ≥ 99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 32 | Ac-Glu (OtBu)-OH | 84192-88-1 | អាហ្គ្រីលីន អាសេទីល octapeptide-3 | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 33 | Ac-β-Ala-OH·DCHA | / | អាសេទីល តេត្រាប៉ិបទីត-៥ | ≥ 99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 34 | Fmoc-ß-Ala-OH | 35737-10-1 | អាសេទីល តេត្រាប៉ិបទីត-៥ | ≥ 99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 35 | Fmoc-Hyp(tBu)-OH | 122996-47-8 | អ៊ីកាទីប៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 36 | Fmoc-Thi-OH | 130309-35-2 | អ៊ីកាទីប៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 37 | Fmoc-D-Tic-OH | 130309-33-0 | អ៊ីកាទីប៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 38 | Fmoc-Oic-OH | 130309-37-4 | អ៊ីកាទីប៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 39 | បូស-ស-អូ | ១៣៧៣៤-៣៦-៦ | សារ៉ាឡាស៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 40 | Fmoc-Sar-OH | 77128-70-2 | សារ៉ាឡាស៊ីន | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 41 | Fmoc-Tyr(SO3Na)-OH.H2O | 106864-37-3 | Sincalide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 42 | Fmoc-D-Asp(OtBu)-OH | 112883-39-3 | ដាបតូមីស៊ីន | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 43 | Ac-Ser(tBu)-OH | 77285-09-7 | អាហ្វាម៉ាឡាណូទីត | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 44 | Boc-HomoCys(Trt)-OH | 201419-16-1 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 45 | Fmoc-HomoCys(Trt)-OH | 167015-23-8 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 46 | Fmoc-Dab-OH | ១៦១៤២០-៨៧-៧ | ពិសពស់ | ≥ 99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
*Max1 = ភាពបរិសុទ្ធមិនស្គាល់អតិបរមា
សូចនាករផ្សេងទៀត៖
- អាស៊ីតអាសេទិក៖ ≤0.02% (ផលិតផលទាំងអស់)
- Ethyl Acetate: ≤0.5% (ផលិតផលទាំងអស់)
- ជាតិអាល់កុល៖ ≤0.5% (ផលិតផលទាំងអស់)
- ភាពមិនបរិសុទ្ធអតិបរមាដែលមិនស្គាល់៖ Fmoc-Trp(Boc)-OH (143824-78-6) ≤0.3%; ផ្សេងទៀត ≤0.2%